BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in KOD — Kodiak Sciences Inc.

CIK 1107261 HOUSTON, TX

Position in KOD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,585,672

+$891,888 QoQ

Shares Held

40,700

+123.6% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#80

of 200 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. KOD ranks #11 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	552,566	$13,372,097
2	INVA	Innoviva, Inc.	350,253	$7,954,245
3	PBYI	Puma Biotechnology, Inc.	791,616	$6,420,005
4	RIGL	Rigel Pharmaceuticals Inc	124,184	$4,858,078
5	EXEL	Exelixis, Inc.	66,100	$3,596,501
6	CRMD	CorMedix Inc.	434,132	$3,407,936
7	KROS	Keros Therapeutics, Inc.	265,017	$2,835,681
8	PTCT	Ptc Therapeutics, Inc.	22,000	$1,794,540

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,585,672	40,700	+123.6%	Shares	Sole	2026-08-14
2026-03-31	$693,784	18,200	-57.9%	Shares	Sole	2026-05-15
2025-12-31	$1,207,872	43,200	-40.2%	Shares	Sole	2026-02-17
2025-09-30	$1,181,914	72,200	-29.1%	Shares	Sole	2025-11-14
2025-06-30	$380,087	101,900	+8.2%	Shares	Sole	2025-08-14
2025-03-31	$264,702	94,200	-32.3%	Shares	Sole	2025-05-15
2024-12-31	$1,385,040	139,200	0.0%	Shares	Sole	2025-02-14
2024-09-30	$363,312	139,200	0.0%	Shares	Sole	2024-11-14
2024-06-30	$327,120	139,200	+21.9%	Shares	Sole	2024-08-14
2024-03-31	$600,692	114,200	0.0%	Shares	Sole	2024-05-15
2023-12-31	$347,168	114,200	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.